Sign in

NCT07443293Active, not recruitingPhase 2

IMPACT 360 for Parkinson's Disease

IMPACT 360 Study for Parkinson's Disease

Source: ClinicalTrials.gov · Last updated 25 Jun 2026

Brief summary (registry, in English)

The IMPACT 360 study will evaluate the effects of a combined intervention of exercise, mindfulness, and nutrition on 8 key indicators of health and the mechanisms that drive these changes. 60 subjects aged 40 to 85 with a current diagnosis Parkinson's disease will be recruited. This study will follow a partial crossover design. All participants will receive the intervention. Participants randomized into the intervention group after their baseline screening will receive the 6-month intervention. Those randomized into the waitlist group will complete another assessment at the end of the 6-month care as usual phase before receiving the intervention.

Status (registry)
Active, not recruiting
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
60 (estimated)
First submitted
24 Feb 2026
Start date
28 Oct 2024
Primary completion date
31 Dec 2026
Lead sponsor
University of British Columbia
NCT number
NCT07443293

What you commit to

  • Study type: Interventional · Phase 2
  • Planned participants: 60
  • From 28 Oct 2024 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Subjects with a history or major episodes of drug or alcohol abuse
  • Ear or eye implant
  • Implanted drug infusion pump
  • Surgery or tattoos (including tattooed eyeliner) in the last six weeks
  • Brain surgery

Other illness

  • Any chronic medical condition which would affect ability to participate in exercise
  • Significant cognitive impairment, depression, or eating disorder
  • Significant or unstable cardiovascular or respiratory disease
  • Chronic/acute bacterial/viral infection
  • GI cancer
  • Inflammatory bowel disease
    • Exclusion for MRI scanning:
  • Artificial heart valve
  • Have a cardiac pacemaker, wires or defibrillator

Lab values

  • Any contraindication for exercise based on the Physical Activity Readiness for Everyone Questionnaire (PAR-Q+) and medical clearance form

Other

  • Score \<21/30 on the Montreal Cognitive Assessment (MoCA)
  • Any contraindication to MRI scanning; such as implanted metal clips or wires (see list below)
  • Participants who were told by a medical doctor that they need to be medically supervised for exercise
  • Participants currently doing 180 minutes or more of moderate-vigorous intensity exercise per week AND either of the following:
    • Completion of a Mindfulness-Based Stress Reduction course OR; Score \>8/15 in the MIND Diet Questionnaire
  • Severe/multiple head trauma(s)
  • Subjects who are pregnant or breastfeeding
  • Individuals weighing \> 400 lbs (limit of MRI machine)
  • Brain aneurysm clip
  • Electrical stimulator for nerves or bones
  • Coil, catheter, or filter in any blood vessel
  • Orthopedic hardware (artificial joint, plate, screws)
  • Other metallic prostheses
  • Shrapnel, bullets, or other metal fragments
  • Have had an injury where a piece of metal lodged in the eye or orbit
  • Have a ferromagnetic aneurysm clip

Who the study is looking for

  • Age 40-85 years
  • A diagnosis of either PD, based on the Movement Disorder Society (MDS) criteria, OR, RBD, through a polysomnography
  • Hoehn \& Yahr score of 1 to 2
  • Able to fill out questionnaires
  • Able to follow instructions and directions as required by the intervention.
  • Have access to the necessary technologies (i.e., a working smartphone for Fitbit, a laptop or tablet for Zoom) as required by the intervention.

Age in the registry: 40 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of British Colombia
Coordinator of this site? Confirm its status
VancouverCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.